Halpern Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$319K Buy
358
+8
+2% +$7.19K 0.08% 45
2024
Q2
$317K Sell
350
-50
-13% -$40K 0.09% 47
2024
Q1
$310K Hold
400
0.09% 44
2023
Q4
$247K Buy
+400
New +$233K 0.08% 50

Other funds holding LLY

Halpern Financial's LLY Position: Q3 2024 in Review

Halpern Financial increased its Eli Lilly (LLY) stake by 2.3% in Q3 2024, buying an estimated $7.19K and bringing the position to 358 shares worth $319K. The position accounts for 0.08% of the portfolio, ranked #45.

Halpern Financial first reported a position in LLY in Q4 2023 and has held it in 4 quarters since. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Halpern Financial held 358 shares of Eli Lilly worth $319K as of Q3 2024.
  • Halpern Financial bought 8 Eli Lilly shares in Q3 2024, an estimated $7.19K.
  • Eli Lilly made up 0.08% of Halpern Financial's portfolio in Q3 2024, its #45 holding.
  • Halpern Financial first reported a position in Eli Lilly in Q4 2023 and has held it in 4 quarters since.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Halpern Financial's 13F filing for Q3 2024, filed 4 Oct 2024.